Cancer
Cancer research at CSHL is devoted to understanding the fundamental biology of human cancer. This strong commitment to studying basic cellular processes is based on the premise that understanding how these processes are altered in cancer cells will ultimately provide a framework for rational therapies. Several technological advances developed at CSHL have given rise to innovative genomic approaches and the development of new mouse models of various cancer types. Together, these provide a powerful pathway for discovery, characterization and validation of genes that contribute to the development and progression of cancer. A unique aspect of the CSHL cancer program is its interactive nature -- scientists are encouraged to share their ideas and work on questions in a synergistic way that far exceeds the power of any single laboratory working in isolation. The primary goal of the cancer program is likewise shared: to improve the diagnosis and treatment of all major forms of cancer.
CSHL is one of approximately 60 institutions supported by the
Cancer Centers Program of the National Cancer Institute (NCI) and has been designated as an NCI Cancer Center since 1987. The CSHL Cancer Center is organized into three main program areas and includes 10 shared resources which support and enhance research efforts at CSHL.
(More about the CSHL Cancer Center)